• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于提高癌症治疗口服生物利用度的纳米医学。

Nanomedicine for increasing the oral bioavailability of cancer treatments.

机构信息

Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia.

Sirius University of Science and Technology, 1 Olympic Ave, 354340, Sochi, Russia.

出版信息

J Nanobiotechnology. 2021 Oct 30;19(1):354. doi: 10.1186/s12951-021-01100-2.

DOI:10.1186/s12951-021-01100-2
PMID:34717658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8557561/
Abstract

Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent decades, the fields of material science and nanomedicine have generated several delivery platforms with high potential for overcoming multiple barriers associated to oral administration. This review describes the properties of several nanodelivery systems that improve the bioavailability of orally administered therapeutics, highlighting their advantages and disadvantages in generating successful anticancer oral nanomedicines.

摘要

口服给药是一种很有吸引力的癌症治疗途径。然而,胃肠道具有特定且高效的物理、化学和生物屏障,这些屏障会降低药物(包括化疗药物)的生物利用度。在最近几十年,材料科学和纳米医学领域已经产生了几种具有高潜力的递药平台,可以克服与口服给药相关的多种障碍。本综述描述了几种可提高口服治疗药物生物利用度的纳米递药系统的特性,重点介绍了它们在生成成功的抗癌口服纳米药物方面的优缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/670179e37bba/12951_2021_1100_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/4a6485560c77/12951_2021_1100_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/af90eb3650c7/12951_2021_1100_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/74d62c00d6e1/12951_2021_1100_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/3a02821b6f43/12951_2021_1100_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/3198a8888cd2/12951_2021_1100_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/cf179c4376ee/12951_2021_1100_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/1396f31056da/12951_2021_1100_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/288c6265b010/12951_2021_1100_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/670179e37bba/12951_2021_1100_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/4a6485560c77/12951_2021_1100_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/af90eb3650c7/12951_2021_1100_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/74d62c00d6e1/12951_2021_1100_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/3a02821b6f43/12951_2021_1100_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/3198a8888cd2/12951_2021_1100_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/cf179c4376ee/12951_2021_1100_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/1396f31056da/12951_2021_1100_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/288c6265b010/12951_2021_1100_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/8557561/670179e37bba/12951_2021_1100_Fig9_HTML.jpg

相似文献

1
Nanomedicine for increasing the oral bioavailability of cancer treatments.用于提高癌症治疗口服生物利用度的纳米医学。
J Nanobiotechnology. 2021 Oct 30;19(1):354. doi: 10.1186/s12951-021-01100-2.
2
Enteral Route Nanomedicine for Cancer Therapy.肠内途径的癌症治疗纳米医学。
Int J Nanomedicine. 2024 Sep 25;19:9889-9919. doi: 10.2147/IJN.S482329. eCollection 2024.
3
Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity.绿茶儿茶素的纳米递呈进展,以增强抗癌活性。
Molecules. 2021 May 31;26(11):3301. doi: 10.3390/molecules26113301.
4
Current prospects and challenges of nanomedicine delivery in prostate cancer therapy.纳米医学在前列腺癌治疗中的应用的现状与挑战。
Nanomedicine (Lond). 2017 Dec;12(23):2675-2692. doi: 10.2217/nnm-2017-0236. Epub 2017 Nov 3.
5
Nanomedicine: An effective tool in cancer therapy.纳米医学:癌症治疗的有效工具。
Int J Pharm. 2018 Apr 5;540(1-2):132-149. doi: 10.1016/j.ijpharm.2018.02.007. Epub 2018 Feb 7.
6
Vitamin E-based nanomedicines for anti-cancer drug delivery.基于维生素 E 的纳米医学用于抗癌药物递送。
J Control Release. 2014 May 28;182:33-44. doi: 10.1016/j.jconrel.2014.03.009. Epub 2014 Mar 12.
7
Oral Nanomedicine: Challenges and Opportunities.口腔纳米医学:挑战与机遇。
Adv Mater. 2024 Feb;36(6):e2306081. doi: 10.1002/adma.202306081. Epub 2023 Nov 30.
8
Tumor-targeted nanomedicines for cancer theranostics.用于癌症诊疗的肿瘤靶向纳米药物。
Pharmacol Res. 2017 Jan;115:87-95. doi: 10.1016/j.phrs.2016.11.014. Epub 2016 Nov 16.
9
Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.用于提高抗逆转录病毒疗法口服生物利用度的纳米制剂策略。
Ther Deliv. 2015;6(4):469-90. doi: 10.4155/tde.15.4.
10
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.抗癌纳米药物设计出了什么问题以及如何纠正
ACS Nano. 2020 Oct 27;14(10):12281-12290. doi: 10.1021/acsnano.9b09713. Epub 2020 Oct 6.

引用本文的文献

1
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances.氧化应激、炎症与衰老中的线粒体:从机制到治疗进展
Signal Transduct Target Ther. 2025 Jun 11;10(1):190. doi: 10.1038/s41392-025-02253-4.
2
Carrier-Free Nanocombo-Sensitized Photoimmunotherapy via Activation of α2-Adrenergic Receptors.通过激活α2-肾上腺素能受体的无载体纳米组合致敏光免疫疗法
ACS Appl Mater Interfaces. 2025 Mar 19;17(11):16437-16452. doi: 10.1021/acsami.4c18052. Epub 2025 Mar 4.
3
Oral Administration of Neratinib Maleate-Loaded Lipid-Polymer Hybrid Nanoparticles: Optimization, Physical Characterization, and In Vivo Evaluation.

本文引用的文献

1
Novel amorphous solid dispersion based on natural deep eutectic solvent for enhancing delivery of anti-tumor RA-XII by oral administration in rats.基于天然深共晶溶剂的新型无定形固体分散体用于提高 RA-XII 经口给药在大鼠体内的递送
Eur J Pharm Sci. 2021 Nov 1;166:105931. doi: 10.1016/j.ejps.2021.105931. Epub 2021 Jul 10.
2
Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents.P-糖蛋白和乳腺癌耐药蛋白的双重抑制可提高啮齿动物口服拓扑替康的生物利用度。
Pharmaceutics. 2021 Apr 15;13(4):559. doi: 10.3390/pharmaceutics13040559.
3
Adequate formulation approach for oral chemotherapy: Etoposide solubility, permeability, and overall bioavailability from cosolvent- vs. vitamin E TPGS-based delivery systems.
口服载有马来酸奈拉替尼的脂质-聚合物杂化纳米颗粒:优化、物理表征及体内评价
Pharmaceutics. 2025 Feb 8;17(2):221. doi: 10.3390/pharmaceutics17020221.
4
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin.增强癌症治疗效果:用于冬凌草甲素的先进纳米载体递送系统
Front Pharmacol. 2024 Dec 3;15:1476739. doi: 10.3389/fphar.2024.1476739. eCollection 2024.
5
Functional Evaluation of Niosomes Utilizing Surfactants in Nanomedicine Applications.利用纳米医学应用中的表面活性剂的尼欧索米的功能评估。
Int J Nanomedicine. 2024 Oct 10;19:10283-10305. doi: 10.2147/IJN.S480639. eCollection 2024.
6
Enteral Route Nanomedicine for Cancer Therapy.肠内途径的癌症治疗纳米医学。
Int J Nanomedicine. 2024 Sep 25;19:9889-9919. doi: 10.2147/IJN.S482329. eCollection 2024.
7
Solubilization of Paclitaxel with Natural Compound Rubusoside toward Improving Oral Bioavailability in a Rodent Model.利用天然化合物甜茶苷增溶紫杉醇以提高啮齿动物模型中的口服生物利用度
Pharmaceutics. 2024 Aug 22;16(8):1104. doi: 10.3390/pharmaceutics16081104.
8
Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design.铁死亡的机制与治疗靶点:对纳米医学设计的启示
J Pharm Anal. 2024 Jul;14(7):100960. doi: 10.1016/j.jpha.2024.03.001. Epub 2024 Mar 8.
9
Mechanism of Action of Dihydroquercetin in the Prevention and Therapy of Experimental Liver Injury.二氢槲皮素防治实验性肝损伤的作用机制。
Molecules. 2024 Jul 27;29(15):3537. doi: 10.3390/molecules29153537.
10
Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy.纳米蛋白酶体靶向嵌合体(Nano-PROTACs)在癌症治疗中的应用。
Int J Nanomedicine. 2024 Jun 12;19:5739-5761. doi: 10.2147/IJN.S448684. eCollection 2024.
口服化疗药物的充分制剂方法:从共溶剂-与维生素 E TPGS 为基础的给药系统的依托泊苷溶解度、渗透性和整体生物利用度。
Int J Pharm. 2021 Mar 15;597:120295. doi: 10.1016/j.ijpharm.2021.120295. Epub 2021 Jan 23.
4
Cancer Patients' Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy: Feasibility Study.癌症患者对一款用于提高居家化疗安全性的智能手机应用程序的感知价值:可行性研究
JMIR Form Res. 2021 Jan 6;5(1):e20636. doi: 10.2196/20636.
5
Bioinspired Polydopamine Coating as an Adhesion Enhancer Between Paraffin Microcapsules and an Epoxy Matrix.受生物启发的聚多巴胺涂层作为石蜡微胶囊与环氧基体之间的粘附增强剂
ACS Omega. 2020 Jul 31;5(31):19639-19653. doi: 10.1021/acsomega.0c02271. eCollection 2020 Aug 11.
6
A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin.一种新型纳米粒子制剂,可增强香叶木苷的胃部黏附性和生物利用度。
Int J Nanomedicine. 2020 Jul 14;15:5073-5082. doi: 10.2147/IJN.S252049. eCollection 2020.
7
Production of polycaprolactone nanoparticles with hydrodynamic diameters below 100 nm.制备流体动力学直径低于100纳米的聚己内酯纳米颗粒。
Eng Life Sci. 2019 Aug 12;19(10):658-665. doi: 10.1002/elsc.201800214. eCollection 2019 Oct.
8
Gut-on-a-chip: Current progress and future opportunities.芯片上的肠道:当前进展与未来机遇
Biomaterials. 2020 Oct;255:120196. doi: 10.1016/j.biomaterials.2020.120196. Epub 2020 Jun 14.
9
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.口服途径递呈肽类药物:制剂和药物化学方法。
Adv Drug Deliv Rev. 2020;157:2-36. doi: 10.1016/j.addr.2020.05.007. Epub 2020 May 29.
10
Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.用于胃肠道区域靶向的口服药物递送进展——生理、病理生理和药学因素的影响
Front Pharmacol. 2020 Apr 28;11:524. doi: 10.3389/fphar.2020.00524. eCollection 2020.